India’s new Prime Minister Narendra Modi has asked Ministers to set ambitious targets for the first 100 days of government,. While the BJP Party Manifesto calls for implementation of incentives for R&D Intensive Enterprises, BioPharma wallahs eagerly await clear signals on IP policy directions, where latest reports indicate that the Modi Government’s first act may be to expand pharma price controls by raising the number of drugs on the essential medicines list.
Image: http://www.biotechblog.com/
To read the original article: What changes will India’s next Prime Minister bring to India’s Innovative Life Sciences? (Part 2) | BiotechBlog
